|
1
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer. 37(Suppl
8): S4–S66. 2001.PubMed/NCBI
|
|
2
|
Jemal A, Thomas A, Murray T and Thun M:
Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002.
View Article : Google Scholar
|
|
3
|
Krejs GJ: Gastric cancer: epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thim L: Trefoil peptides: from structure
to function. Cell Mol Life Sci. 53:888–903. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoffmann W, Jagla W and Wiede A: Molecular
medicine of TFF-peptides: from gut to brain. Histol Histopathol.
16:319–334. 2001.PubMed/NCBI
|
|
6
|
Wright NA, Hoffmann W, Otto WR, Rio MC and
Thim L: Rolling in the clover: trefoil factor family (TFF)-domain
peptides, cell migration and cancer. FEBS Lett. 408:121–123. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rio MC, Bellocq JP, Daniel JY, et al:
Breast cancer-associated pS2 protein: synthesis and secretion by
normal stomach mucosa. Science. 241:705–708. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rio MC, Chenard MP, Wolf C, et al:
Induction of pS2 and hSP genes as markers of mucosal ulceration of
the digestive tract. Gastroenterology. 100:375–379. 1991.PubMed/NCBI
|
|
9
|
Wright NA, Poulsom R, Stamp G, et al:
Trefoil peptide gene expression in gastrointestinal epithelial
cells in inflammatory bowel disease. Gastroenterology. 104:12–20.
1993.PubMed/NCBI
|
|
10
|
Kjellev S: The trefoil factor family -
small peptides with multiple functionalities. Cell Mol Life Sci.
66:1350–1369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henry JA, Bennett MK, Piggott NH, Levett
DL, May FE and Westley BR: Expression of the pNR-2/pS2 protein in
diverse human epithelial tumours. Br J Cancer. 64:677–682. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Machado JC, Carneiro F, Blin N and
Sobrinho-Simoes M: Pattern of pS2 protein expression in
premalignant and malignant lesions of gastric mucosa. Eur J Cancer
Prev. 5:169–179. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lefebvre O, Chenard MP, Masson R, et al:
Gastric mucosa abnormalities and tumorigenesis in mice lacking the
pS2 trefoil protein. Science. 274:259–262. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calnan DP, Westley BR, May FE, Floyd DN,
Marchbank T and Playford RJ: The trefoil peptide TFF1 inhibits the
growth of the human gastric adenocarcinoma cell line AGS. J Pathol.
188:312–317. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bossenmeyer-Pourie C, Kannan R, Ribieras
S, et al: The trefoil factor 1 participates in gastrointestinal
cell differentiation by delaying G1-S phase transition and reducing
apoptosis. J Cell Biol. 157:761–770. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prest SJ, May FE and Westley BR: The
estrogen-regulated protein, TFF1, stimulates migration of human
breast cancer cells. FASEB J. 16:592–594. 2002.PubMed/NCBI
|
|
17
|
Ather MH, Abbas F, Faruqui N, Israr M and
Pervez S: Expression of pS2 in prostate cancer correlates with
grade and Chromogranin A expression but not with stage. BMC Urol.
4:142004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arumugam T, Brandt W, Ramachandran V, et
al: Trefoil factor 1 stimulates both pancreatic cancer and stellate
cells and increases metastasis. Pancreas. 40:815–822. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanchez-Pulido L, Devos D and Valencia A:
BRICHOS: a conserved domain in proteins associated with dementia,
respiratory distress and cancer. Trends Biochem Sci. 27:329–332.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshikawa Y, Mukai H, Hino F, Asada K and
Kato I: Isolation of two novel genes, down-regulated in gastric
cancer. Jpn J Cancer Res. 91:459–463. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toback FG, Walsh-Reitz MM, Musch MW, et
al: Peptide fragments of AMP-18, a novel secreted gastric antrum
mucosal protein, are mitogenic and motogenic. Am J Physiol
Gastrointest Liver Physiol. 285:G344–G353. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Walsh-Reitz MM, Huang EF, Musch MW, et al:
AMP-18 protects barrier function of colonic epithelial cells: role
of tight junction proteins. Am J Physiol Gastrointest Liver
Physiol. 289:G163–G171. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baus-Loncar M, Lubka M, Pusch CM, Otto WR,
Poulsom R and Blin N: Cytokine regulation of the trefoil factor
family binding protein GKN2 (GDDR/TFIZ1/blottin) in human
gastrointestinal epithelial cells. Cell Physiol Biochem.
20:193–204. 2007.
|
|
24
|
Westley BR, Griffin SM and May FE:
Interaction between TFF1, a gastric tumor suppressor trefoil
protein, and TFIZ1, a brichos domain-containing protein with
homology to SP-C. Biochemistry. 44:7967–7975. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Otto WR and Thim L: Trefoil factor
family-interacting proteins. Cell Mol Life Sci. 62:2939–2946. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kouznetsova I, Laubinger W, Kalbacher H,
et al: Biosynthesis of gastrokine-2 in the human gastric mucosa:
restricted spatial expression along the antral gland axis and
differential interaction with TFF1, TFF2 and mucins. Cell Physiol
Biochem. 20:899–908. 2007. View Article : Google Scholar
|
|
27
|
Stolte M and Meining A: The updated Sydney
system: classification and grading of gastritis as the basis of
diagnosis and treatment. Can J Gastroenterol. 15:591–598.
2001.PubMed/NCBI
|
|
28
|
Beckler AD, Roche JK, Harper JC, et al:
Decreased abundance of trefoil factor 1 transcript in the majority
of gastric carcinomas. Cancer. 98:2184–2191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moss SF, Lee JW, Sabo E, et al: Decreased
expression of gastrokine 1 and the trefoil factor interacting
protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology
and relationship to prognosis. Clin Cancer Res. 14:4161–4167. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
May FE, Griffin SM and Westley BR: The
trefoil factor interacting protein TFIZ1 binds the trefoil protein
TFF1 preferentially in normal gastric mucosal cells but the
co-expression of these proteins is deregulated in gastric cancer.
Int J Biochem Cell Biol. 41:632–640. 2009. View Article : Google Scholar
|
|
31
|
Rippa E, La Monica G, Allocca R, Romano
MF, De Palma M and Arcari P: Overexpression of gastrokine 1 in
gastric cancer cells induces fas-mediated apoptosis. J Cell
Physiol. 226:2571–2578. 2011. View Article : Google Scholar : PubMed/NCBI
|
